Summary:
- The article reports that fewer than half of U.S. jails provide life-saving medications for opioid use disorder (OUD), such as methadone and buprenorphine, despite evidence that these medications can reduce overdose deaths and improve health outcomes for incarcerated individuals.
- The article cites a study published in the Journal of the American Medical Association (JAMA) Network Open, which found that only 40% of jails in the U.S. offer these medications, even though they are the standard of care for treating OUD.
- The article highlights the importance of expanding access to these medications in jails, as incarcerated individuals with OUD are at a high risk of overdose upon release, and providing treatment during incarceration can help reduce this risk and improve overall health outcomes.